Abstract:SummaryNebivolol, a {iI-selective {i-blocker, was studied over a period of 6 months in patients with hypertension. The purpose of the study was to determine the efficacy, dose range and tolerability of the drug.42 patients with hypertension were recruited into the study. After a 4-week placebo run-in, patients received nebivolol 5, 7.5 or IOmg sequentially until normalisation of blood pressure was achieved. Blood pressure was measured (using a Hawksley random-zero sphygmomanometer) after 5 minutes in the supin… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.